Trial intelligence / Profile preview

5% dextrose water versus triamcinolone injection for mild to moderate carpal tunnel syndrome

IRCT20180209038673N4Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Apr 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in carpal tunnel syndrome (CTS) comparing 5% dextrose water injection with triamcinolone acetonide injection (2 arms). Primary endpoint: Pain severity. Started Apr 2018; status: completed.

02

Drugs

dextrosetriamcinolone acetonide
03

Conditions

carpal tunnel syndrome (CTS)

Beyond the preview

Go deeper on IRCT20180209038673N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180209038673N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call